Computational approach based on freely accessible tools for antimicrobial drug design

Area of Science:

• Computational chemistry and drug discovery.
• Pharmacology and medicinal chemistry.

Background:

• Antimicrobial drug development is vital due to rising pandemics and antimicrobial resistance.
• In silico assays offer a faster, cost-effective alternative to traditional in vitro screening for identifying drug candidates.
• In vitro and in vivo studies remain critical for validating drug efficacy.

Purpose of the Study:

• To outline a computational protocol for identifying novel antimicrobial agents using only freely available tools.
• To provide a resource applicable to broad drug design strategies.
• To review computational methods and protein-ligand interactions relevant to drug discovery.

Main Methods:

• Development of an in silico protocol for virtual screening of potential antimicrobial compounds.
• Utilizing exclusively free computational software and databases.
• Reviewing established computational techniques for drug design and analysis.

Main Results:

• A comprehensive in silico protocol for identifying antimicrobial drug candidates has been established.
• The protocol leverages accessible computational tools, reducing financial barriers.
• Key computational methods and protein-ligand interaction principles are summarized.

Conclusions:

• The presented in silico protocol offers an efficient and economical method for discovering new antimicrobial agents.
• This approach supports rational drug design and accelerates the early stages of therapeutic development.
• The protocol is adaptable for broader drug discovery applications beyond antimicrobials.